Novel Pyrimidine-1,3,4-Oxadiazole Hybrids and Their Precursors As Potential Antimycobacterial Agents

References

• WHO . Global Tuberculosis Report 2020. World Health Organization (2020). https://apps.who.int/iris/rest/bitstreams/1312164/retrieve
   Google Scholar
• WHO . Tuberculosis and COVID-19 (2020). www.who.int/teams/global-tuberculosis-programme/covid-19
   Google Scholar
• WHO . WHO announces updated definitions of extensively drug-resistant tuberculosis (2021). www.who.int/news/item/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis/
   Google Scholar
• Rahama O , ThakerH. Atypical mycobacteria: an important differential for the general physician. Clin. Med.13, 504–506 (2013).
   PubMed Web of Science ®Google Scholar
• Perez-Miranda J , TraversiL , PolverinoE. Atypical mycobacteria in bronchiectasis. When do we treat it?Arch. Bronconeumol. (Engl. Ed.)55(4), 183–184 (2019).
   PubMed Web of Science ®Google Scholar
• Lu HJ , WangHH , ZhaoHY , ZhangDF. Recent advances in oxazolidinones as antituberculosis agents. Future Med. Chem.14, 1149–1165 (2022).
   PubMed Web of Science ®Google Scholar
• Finger V , KufaM , SoukupO , CastagnoloD , RohJ , KorabecnyJ. Pyrimidine derivatives with antitubercular activity. Eur. J. Med. Chem.246, 114946 (2023).
   PubMed Web of Science ®Google Scholar
• Alexandrova LA , KhandazhinskayaAL , MatyuginaES , MakarovDA , KochetkovSN. Analogues of pyrimidine nucleosides as mycobacteria growth inhibitors. Microorganisms10, 1299 (2022).
   PubMed Web of Science ®Google Scholar
• Imran M , KhanSA , AsdaqSMBet al. An insight into the discovery, clinical studies, compositions, and patents of macozinone: a drug targeting the DprE1 enzyme of Mycobacterium tuberculosis. J. Infect. Public Health15, 1097–1107 (2022).
   PubMed Web of Science ®Google Scholar
• Navarrete-Vázquez G , Molina-SalinasGM , Duarte-FajardoZVet al. Synthesis and antimycobacterial activity of 4-(5-substituted-1, 3, 4-oxadiazol-2-yl)pyridines. Bioorg. Med. Chem.15, 5502–5508 (2007).
   PubMed Web of Science ®Google Scholar
• Vosátka R , KrátkýM , ŠvarcováMet al. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: synthesis, antimycobacterial activity and investigation of their mechanism of action. Eur. J. Med. Chem.151, 824–835 (2018).
   PubMed Web of Science ®Google Scholar
• Yang R , CaoW , LiuSet al. Evaluation of a novel inhibitor of aspartate semialdehyde dehydrogenase as a potent antitubercular agent against Mycobacterium tuberculosis. J. Antibiot.75, 333–340 (2022).
   PubMed Web of Science ®Google Scholar
• Metre TV , JoshiSD , KodasiBet al. L-proline catalyzed ring transformation of 5-substituted tetrazole to 1,3,4-oxadiazoles as anti-tubercular agents. Synth. Commun.52(13–14), 1500–1516 (2022).
   Web of Science ®Google Scholar
• Wang A , XuS , ChaiYet al. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents. Bioorg. Med. Chem.53, 116529 (2022).
   Web of Science ®Google Scholar
• De SS , KhambeteMP , DeganiMS. Oxadiazole scaffolds in anti-tuberculosis drug discovery. Bioorg. Med. Chem. Lett.29(16), 1999–2007 (2019).
   PubMed Web of Science ®Google Scholar
• Glomb T , ŚwiątekP. Antimicrobial activity of 1,3,4-oxadiazole derivatives. Int. J. Mol. Sci.22, 6979 (2021).
   PubMed Web of Science ®Google Scholar
• Verma SK , VermaR , VermaS , VaishnavY , TiwariSP , RakeshKP. Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: a key review. Eur. J. Med. Chem.209, 112886 (2021).
   PubMed Web of Science ®Google Scholar
• Servusova-Vanaskova B , JandourekO , PaterovaPet al. Alkylamino derivatives of N-benzylpyrazine-2-carboxamide: synthesis and antimycobacterial evaluation. MedChemComm.6(7), 1311–1317 (2015).
   Web of Science ®Google Scholar
• Ivasiv V , AlbertiniC , GonçalvesAE , RossiM , BolognesiML. Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases. Curr. Top. Med. Chem.19, 1694–1711 (2019).
   PubMed Web of Science ®Google Scholar
• Lawhorn BG , PhilpJ , ZhaoYet al. Identification of purines and 7-deazapurines as potent and selective type I inhibitors of troponin I-interacting kinase (TNNI3K). J. Med. Chem.58(18), 7431–7448 (2015).
   PubMed Web of Science ®Google Scholar
• Shaikh AS , KiranmaiG , DeviGPet al. Exploration of mercaptoacetamide-linked pyrimidine-1,3,4-oxadiazole derivatives as DNA intercalative topo II inhibitors: cytotoxicity and apoptosis induction. Bioorg. Med. Chem. Lett.65, 128697 (2022).
   PubMed Web of Science ®Google Scholar
• El Mansouri A , OubellaA , DânounKet al. Discovery of novel furo[2, 3-d]pyrimidin-2-one-1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis. Arch. Pharm.354, e2100146 (2021).
   PubMed Web of Science ®Google Scholar
• Wyeth LLC . Ayral-KaloustianS , MansourTK , TsouHRet al.3-Substituted-1H-pyrrolo[2,3-b]pyridine and 3-substituted-1H-pyrrolo[3, 2-b]pyridine compounds, their use as mTOR kinase and pi3 kinase inhibitors, and their syntheses. WO2010/030727, A1 (2010).
   Google Scholar
• Pflégr V , Štěpánkovአ, SvrčkováK , ŠvarcováM , VinšováJ , KrátkýM. 5-Aryl-1,3,4-oxadiazol-2-amines decorated with long alkyl and their analogues: synthesis, acetyl- and butyrylcholinesterase inhibition and docking study. Pharmaceuticals15, 400 (2022).
   Web of Science ®Google Scholar
• Pflégr V , HorváthL , StolaříkováJet al. Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity. Eur. J. Med. Chem.223, 113668 (2021).
   PubMed Web of Science ®Google Scholar
• Krátký M , BaranyaiZ , Štěpánkovአ, SvrčkováK , ŠvarcováM , StolaříkováJ , HorváthL , BőszeS , VinšováJ. N-Alkyl-2-[4-(trifluoromethyl)benzoyl]hydrazine-1-carboxamides and their analogues: synthesis and multitarget biological activity. Molecules25, 2268 (2020).
   PubMed Web of Science ®Google Scholar
• Folch J , LeesM , SloaneStanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem.226, 497–509 (1957).
   PubMed Web of Science ®Google Scholar
• Brecik M , CentarovaI , MukherjeeRet al. DprE1 Is a vulnerable tuberculosis drug target due to its cell wall localization. ACS Chem. Biol.10, 1631–1636 (2015).
   PubMed Web of Science ®Google Scholar
• Karabanovich G , DusekJ , SavkovaKet al. Development of 3,5-dinitrophenyl-containing 1,2,4-triazoles and their trifluoromethyl analogues as highly efficient antitubercular agents inhibiting decaprenylphosphoryl-β-D-ribofuranose 2′-oxidase. J. Med. Chem.62, 8115–8139 (2019).
   PubMed Web of Science ®Google Scholar